Legacy MEDSearch

JULY 19, 2023

VAPOR 2 is a prospective, multicenter, single-arm study that will treat 235 patients with intermediate-risk, localized prostate cancer at up to 30 U.S. The therapy is designed to ablate cancer cells while protecting surrounding structures, lessening the likelihood of life-altering side effects common with other prostate cancer treatments.

Medical 52

Medical Side effects Patients Recruitment 52

Pharma Leaders

MAY 18, 2023

We are excited about the prospect of working collaboratively with the FDA to finalise this review over the next few months. “We Diarrhea was the most common side effect with XPHOZAH. The biopharmaceutical company expects XPHOZAH to be commercially available in Q4 2023 after an approval from the regulatory body.

Food and Drug Administration 52

Food and Drug Administration FDA Side effects Prospecting 52

pharmaphorum

SEPTEMBER 28, 2022

Most side effects with exa-cel in clinical trials were consistent with that process, similar to the approach taken to treat SCD and thalassaemia using a bone marrow transplant, which requires a matched donor. The post Vertex, CRISPR prep filing for gene-editing blood disorder therapy appeared first on.

Side effects 59

Side effects Prospecting Marketing Patients 59

Pharmaceutical Representative Training

OCTOBER 9, 2024

Introduction Every sales professional has experienced deals collapsing at the last minute due to objections from prospects. In the competitive world of pharmaceutical sales, effectively handling customer objections is crucial for success. There are times when your prospect will have multiple objections at once.

Sales 52

Sales Pharma Pharmaceutical Sales Prospecting 52

Toolyt

NOVEMBER 11, 2021

It is a rare arena where the prospects have more knowledge about medicines and diseases than the seller. Explain the side effects of the particular drug. Effects And Counter-effect Of Drugs & Medicines. It is critical to share the information with the doctor about its effects and side effects.

Medical sales reps 52

Medical sales reps Medical sales Doctors Training 52

European Pharmaceutical Review

JUNE 12, 2024

The specific representation of these events differed between the treatments, highlighting potential differences in side effect profiles that should be explored in further studies. Overall, MBK-01 has potential to be an effective, easy-to-administer, low-risk treatment for CDI. percent for MBK-01 and 4.26

Safety 111

Safety Patients Side effects Management 111

pharmaphorum

OCTOBER 1, 2022

Shares in the company lost around 16% of their value after the top-line result of the REVERSE study in patients with compensated NASH-related cirrhosis were announced, as investors tried to work out what the failure will mean for the drug’s prospects.

Side effects 59

Side effects FDA Prospecting Pharma 59

pharmaphorum

OCTOBER 11, 2022

That makes leniolisib important for Pharming’s future growth prospects while it works on new uses for Ruconest in areas like acute kidney injury and a gene therapy for HAE partnered with Orchard Therapeutics.

Side effects 52

Side effects Competition Sales Prospecting 52

Pharmaceutical Representative Training

FEBRUARY 29, 2024

PSRs must possess a robust understanding of pharmacology, adeptly navigating inquiries on drug mechanisms, side effects, and interactions. Explore the allure of pharmaceutical sales, offering recession-proof stability coupled with lucrative salary prospects, benefits, and flexibility. Why Choose Pharma Sales?

Sales 52

Sales Pharma Pharmaceutical Sales Pharma sales reps 52

Pharmaceutical Representative Training

JANUARY 8, 2025

1] How can mastering pharmacology give sales reps a competitive advantage when meeting with prospective HCPs? The rep also elaborates on this concern with clinical trial results showing no significant side effects in older adults due to prolonged drug concentrations or toxicities. CNPR Pharmaceutical Sales Program.

Pharmacology 52

Pharmacology Pharma sales reps Sales Pharma 52

PM360

SEPTEMBER 30, 2024

The hypersegmentation and rapid evolution of most oncology landscapes, driven by scientific advancements, global regulatory changes, and an increasing focus on value-based medicine, make this a challenging prospect. Serious” side effects?

Side effects 52

Side effects Marketing Patients Specialization 52

pharmaphorum

SEPTEMBER 15, 2022

Prospects for reproxalap looked bleak last year after the drug failed to improve on placebo in treating ocular redness, the primary endpoint of its TRANQUILITY phase 3 trial, although it did show improvement n other measures including tear production. Sales were nevertheless solid at $468 million and $1.29 billion respectively last year.

FDA 52

FDA Side effects Prospecting Patients 52

European Pharmaceutical Review

OCTOBER 24, 2024

Nevertheless, both efficiently clear amyloid and have a similar slowing effect on progression of cognitive decline in patients”. However, side effects of these drugs, such as “the development of amyloid-related imaging abnormalities (ARIAs), remains a significant concern”. billion and $2.0 billion in 2030, respectively.”

Food and Drug Administration 52

Food and Drug Administration Side effects Medicine Patients 52

PM360

AUGUST 9, 2022

The 2021 PURE report indicated that two out of three patients are concerned about potential side effects before taking their first dose, and again, this is more evident in women than men. Hospital Admissions Associated with Medication Non-Adherence: A Systematic Review of Prospective Observational Studies.” References: 1.

Education 59

Education Side effects Physicians Patients 59

European Pharmaceutical Review

JULY 20, 2023

She stated that some of the key concerns were around viral safety, immunogenicity and the fact that long term side effects are unknown. For cell and gene therapy, a “big issue” she stated, was the complexity of manufacturing. For these therapies, Warner highlighted their short shelf life and scale up.

Consulting 74

Consulting Manufacturing Side effects Safety 74

Pharmaceutical Technology

JANUARY 22, 2023

Santhera’s new therapy binds to the same receptors as corticosteroids, but modifies the downstream activities of the receptors, potentially avoiding the side effects seen with corticosteroids. rises/second (SD 0.0628) in the placebo group. Access the report to: Benchmark the impact of major themes on the Biopharmaceutical industry.

FDA 126

FDA Safety Pharmaceutical Patients 126

Pharmaceutical Technology

MAY 31, 2023

Subjects were dosed over seven days, and reportedly only experienced mild to moderate side effects with no withdrawals. We highlight the most impactful emerging technologies, as well as the industry, regulatory, and macroeconomic factors that influence growth prospects.

Food and Drug Administration 98

Food and Drug Administration Safety Side effects FDA 98

Pharmaceutical Technology

NOVEMBER 30, 2022

In the past, obesity medications were often dismissed due to insufficient efficacy data and the fact that they were associated with a high occurrence of side effects. We highlight the most impactful emerging technologies, as well as the industry, regulatory, and macroeconomic factors that influence growth prospects.

Medical 105

Medical Manufacturing Insurance Side effects 105

Pharmaceutical Technology

NOVEMBER 30, 2022

In the past, obesity medications were often dismissed due to insufficient efficacy data and the fact that they were associated with a high occurrence of side effects. We highlight the most impactful emerging technologies, as well as the industry, regulatory, and macroeconomic factors that influence growth prospects.

Medical 98

Medical Manufacturing Insurance Side effects 98

LEVO Health

AUGUST 22, 2022

In the early stages of the patient journey, prospects are typically just becoming aware of their condition that needs to be addressed, or they are now deciding to take action about an ongoing issue. How to manage common side effects. Step 1: Awareness and Research . This type of information could include tips on: .

Marketing 52

Marketing Patients Physicians Healthcare 52

PM360

AUGUST 26, 2024

As cost constraints and care rationing under the transition to corporatist “value-based” care, any reduction in cost, misdiagnosis, non-targeted treatment, and unnecessary side effects must shift focus of care from reaction to prediction, and from Rx cycling to prevention. Bright Spots.

Medicine 52

Medicine Food and Drug Administration Government Insurance 52

Pharmaceutical Technology

JUNE 5, 2023

With a higher expression of PD-1 and VEGF in tumour tissue and the tumour microenvironment, Summit claims that ivonescimab can more effectively target tumour tissue to provide safer treatment with fewer side effects. The ivonescimab data comes at a significant time for Summit.

Side effects 52

Side effects Patients Leads Prospecting 52

Rep-Lite

MARCH 14, 2024

Even the knowledge of healthcare economics helps communicate the value proposition of their products in the context of cost-effectiveness and improved patient outcomes. Pharmaceutical Knowledge Thorough pharmaceutical product knowledge in pharmaceutical sales includes therapeutic indications, dosing, and side effects.

Medical sales reps 52

Medical sales reps Medical sales Sales Medical 52

European Pharmaceutical Review

AUGUST 25, 2022

the promise of leveraging oncolytic viruses stands out because of their excellent safety profile, minimal predicted side effects and potent ability to kill cancer cells while leaving healthy cells unscathed2. Prospects are hopeful as they are built upon decades of research establishing the incredible power of oncolytic viruses.

Side effects 111

Side effects Safety Patients Engineering 111

European Pharmaceutical Review

JUNE 16, 2023

The consolidation of extensive data into a centralised repository enables enhanced identification of adverse drug interactions, rarer side effects and differences in response among diverse patient populations.

Safety 111

Safety Electronics Recruitment Patients 111

Medico Reach

FEBRUARY 8, 2023

With the use of trailblazing digital platforms, cost-effective technologies, big data analytics, blockchain, and artificial intelligence (AI), the landscape is undergoing a massive transition. The Grand View Research published a report highlighting the stark growth prospects of the pharma industry. billion during 2020-2024.

Pharma 52

Pharma Medicine Marketing Prospecting 52

Legacy MEDSearch

OCTOBER 25, 2023

The study included 409 participants across the entire USA who used Nerivio device for acute treatment of migraine for 12 consecutive months, reporting their data prospectively. We designed Nerivio with exactly these requirements in mind.”

Side effects 52

Side effects Recruitment Networking Management 52

pharmaphorum

DECEMBER 14, 2022

The decision – by eight votes to three – came mainly because panellists were unconvinced by the efficacy of the drug in heart failure with reduced ejection fraction (HFrEF), and so were uncomfortable with its side effects, which include cardiotoxicity such as myocardial ischemia. with omecamtiv mecarbil from 39.1%

FDA 52

FDA Side effects Prospecting Patients 52

Pharmaceutical Technology

MAY 31, 2023

The document would include the drug/biological product name, side effects, directions for use, safety information, and a concise summary of indications and uses. We highlight the most impactful emerging technologies, as well as the industry, regulatory, and macroeconomic factors that influence growth prospects.

Prescription 52

Prescription FDA Food and Drug Administration Medical 52

Pharmaceutical Technology

MARCH 24, 2023

Fox says adjuvant protein subunit vaccines can be a safer approach compared to live attenuated virus vaccines as there is a minimized risk of developing side effects. We highlight the most impactful emerging technologies, as well as the industry, regulatory, and macroeconomic factors that influence growth prospects.

Pharma 64

Pharma Side effects Marketing Biopharma 64

Nixon Gwilt Law

NOVEMBER 5, 2021

Once the PHE ends, the payment mechanism will revert to the established methodology—the RHC All Inclusive Rate (AIR) or the FQHC Prospective Payment System (PPS), and these providers would no longer be able to bill for these services unless they’re delivered in person.

Physicians 52

Physicians Professional Services Medical Side effects 52